Disc up another 5.4% last night on impressive volume to a market cap of $2.5 Billion AUD. That is more than three times the valuation of CUV. CUV has the FDA, EMA drug and the absolute monopoly on EPP and great cash and profits with a Phase 3 into blockbuster Vitiligo. Loss making Disc just hoping to one day in many years to achieve approval in EPP and enter that market. I think it's fair to say shorters have had a big impact here at CUV as ASIC daily data shows and some effort needs to be made to protect shareholder interests right now via a share buyback. Disc is also so much better at attracting investor interest than at CUV and they need to lift their game a lot in that area - after all the newsletter stated it only took one institution buying a lot of shares in one month to take the CUV price over $40.
All IMO DYOR
- Forums
- ASX - By Stock
- CUV
- Disc Medicine - Best comparison stock to Clinuvel
Disc Medicine - Best comparison stock to Clinuvel, page-16
-
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$14.67 |
Change
-0.310(2.07%) |
Mkt cap ! $746.6M |
Open | High | Low | Value | Volume |
$14.99 | $15.02 | $14.67 | $569.1K | 38.28K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1352 | $14.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.70 | 182 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1352 | 14.670 |
2 | 88 | 14.660 |
4 | 1174 | 14.650 |
5 | 315 | 14.640 |
2 | 147 | 14.630 |
Price($) | Vol. | No. |
---|---|---|
14.700 | 182 | 11 |
14.710 | 78 | 3 |
14.720 | 48 | 1 |
14.730 | 45 | 1 |
14.740 | 295 | 5 |
Last trade - 13.19pm 29/07/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |